C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/11 (2006.01) A61K 9/14 (2006.01) A61P 9/10 (2006.01) C07H 21/04 (2006.01)
Patent
CA 2534971
The invention provides compositions and methods for the treating disease using aptamers having 5~-5~and 3~-3~ inverted nucleotide capped ends. In particular, the invention provides 5~-5~ and 3~-3~ capped and-VEGF aptamers of the treatment of neovascularization-related diseases and disorders including age- related macular degeneration.
L'invention concerne des compositions et des procédés de traitement de maladies au moyen d'aptamères possédant des coiffes 5'-5' et 3'-3' nucléotidiques inversées. L'invention concerne en particulier des aptamères anti-VGEF à coiffes 5'-5' et 3'-3' destinés au traitement de maladies et des troubles associés à la néovascularisation, notamment la dégénérescence maculaire liée à l'âge.
Adamis Anthony P.
Calias Perry
Shima David
Wincott Francine
(osi) Eyetech Inc.
Cassan Maclean
Eyetech Pharmaceuticals Inc.
LandOfFree
5'-and 3'-capped aptamers and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5'-and 3'-capped aptamers and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5'-and 3'-capped aptamers and uses therefor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1564384